Evidence map›Paper›PMID 29238913›Full record

ArticleStem cell reviews and reports2018

Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition.

Young-Jun Choi, Hyemin Kim, Ji-Woo Kim, Chang-Woo Song, Dae-Sung Kim, Seokjoo Yoon, Han-Jin Park

Abstract read
PubMed Publisher
In one paragraph

Article in Stem cell reviews and reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. [Culture of pluripotent stem cell-derived hepatocytes and organoids].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
  3. Article
  4. PPTS Inhibits the TGF-Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Young-Jun ChoiDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Hyemin KimDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Ji-Woo KimDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Chang-Woo SongDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Dae-Sung KimDepartment of Biotechnology, Brain Korea 21, Korea University, Seoul, 02841, Republic of Korea.
Seokjoo YoonDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Han-Jin ParkDepartment of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea. hjpark@kitox.re.kr.ORCID 0000-0002-0113-4145
Korea Institute of Toxicology · KRKorea University · KR

Funding

National Research Foundation of Korea (KR) NRF-2012M3A9C7050138National Research Foundation of Korea (KR) NRF-2015R1C1A2A01051471
6 · The paper itself

Abstract

During liver development, nonpolarized hepatic progenitor cells differentiate into mature hepatocytes with distinct polarity. This polarity is essential for maintaining the intrinsic properties of hepatocytes. The balance between the epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) plays a decisive role in differentiation of polarized hepatocytes. In this study, we found that phthalazinone pyrazole (PP), a selective inhibitor of Aurora-A kinase (Aurora-A), suppressed the EMT during the differentiation of hepatocyte-like cells (HLCs) from human embryonic stem cells. The differentiated HLCs treated with PP at the hepatoblast stage showed enhanced hepatic morphology and functions, particularly with regard to the expression of drug metabolizing enzymes. Moreover, we found that these effects were mediated though suppression of the AKT pathway, which is involved in induction of the EMT, and upregulation of hepatocyte nuclear factor 4α expression rather than Aurora-A inhibition. In conclusion, these findings provided insights into the regulatory role of the EMT on in vitro hepatic maturation, suggesting that inhibition of the EMT may drive transformation of hepatoblast cells into mature and polarized HLCs.

Indexed as

Cell DifferentiationCell ProliferationCells, CulturedEpithelial-Mesenchymal TransitionHepatocytesHuman Embryonic Stem CellsHumansImmunohistochemistryLiverPyrazolesPyrazolesEpithelial-mesenchymal transitionHepatocyte-like cellsMesenchymal-epithelial transitionPhthalazinone pyrazolePolarity

Identifiers

PMID29238913
OpenAlexW2773970021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.